Cite
HARVARD Citation
Taki, E. et al. (2022). Cabotegravir/Rilpivirine: the last FDA-approved drug to treat HIV. Expert review of anti-infective therapy. 20 (8), pp. 1135-1147. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Taki, E. et al. (2022). Cabotegravir/Rilpivirine: the last FDA-approved drug to treat HIV. Expert review of anti-infective therapy. 20 (8), pp. 1135-1147. [Online].